Davies et al. [36] hypothesized that hippocampal upregulation of neuropeptides, including orexins and their receptors (OXR), could be involved in the AD pathophysiology, since the patients have increased nocturnal activity, excessive daytime sleepiness and weight loss. The gene discussed is HCRT; the disease is Alzheimer disease.